GMP-Ready NGS Platform for Accelerated Analytical Testing of mRNA Therapeutics

Genedata Selector

As mRNA-based therapeutics evolve, the need for precise, high-throughput analytical testing increases. Next-generation sequencing (NGS) offers the sensitivity and scalability required to monitor critical quality attributes (CQAs) across the entire development lifecycle.

Genedata Selector^® enables biopharma organizations to bring NGS workflows in-house, streamlining data analysis, ensuring regulatory compliance, and reducing turnaround times. With built-in automation, GMP-ready features, and robust data governance, the platform supports efficient, end-to-end mRNA analytics from discovery to manufacturing.